CSIMarket
 


Intellia Therapeutics Inc   (NTLA)
Other Ticker:  
 


Intellia Therapeutics Inc 's Net Profit Margin by quarter

Trends, Rankings, Statistics



NTLA Net Profit Margin (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Revenue Change -9.6 % -3.11 % 12.03 % 5.59 % 84.15 %
Seq. Revenue Change -11.78 % 7.84 % -7.12 % 2.31 % -5.45 %
Revenue In Millions $11.99 $13.59 $12.61 $13.57 $13.27
Net Profit Margin -1019.21 % -909.82 % -818.07 % -835.53 % -853.53 %
Net Profit Margin Total Ranking # # # # #
Net Income In Millions $-122.22 $-123.68 $-103.13 $-113.41 $-113.23
Y / Y Net Income Change - - - - -
Seq. Net Income Change - - - - -


Commenting Third Quarter 2023 Net Profit Margin
Intellia Therapeutics Inc Net Loss of -122 fell compare to Net Loss of $-123.68 millions a quarter before.

Observing third quarter 2023 results within In Vitro & In Vivo Diagnostic Substances industry Intellia Therapeutics Inc has achieved highest Net Profit Margin. While overall Net Profit Margin ranking remained unchanged compare to previous quarter at no. .
Net Margin Formula
NTLA's Net Profit Margin third quarter 2023 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry #
Healthcare Sector #
Overall # 0

Net Profit Margin Statistics
High Average Low
0 % 0 % 0 %
 




Other Net Profit Margin Profitability Ratios
NTLA's Cumulative Net Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Net Profit Margin Trends and Statistics
Healthcare Sector Net Profit Margin Statistics
Net Profit Margin Profitability Trends for overall market
NTLA's Net Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Net Profit Margin
Lowest Ranking Net Profit Margin
Net Profit Margin Profit Margin for NTLA's Competitors
Net Profit Margin Profit Margin for Intellia Therapeutics Inc 's Suppliers
Net Profit Margin Profit Margin for NTLA's Customers

You may also want to know
NTLA's Annual Growth Rates NTLA's Profitability Ratios NTLA's Asset Turnover Ratio NTLA's Dividend Growth
NTLA's Roe NTLA's Valuation Ratios NTLA's Financial Strength Ratios NTLA's Net Income Growth
NTLA's Roa NTLA's Inventory Turnover Ratio NTLA's Growth Rates NTLA's Dividend Comparisons


Companies with similar Net Profit Margin in the quarter ending Sep 30 2023, within In Vitro & In Vivo Diagnostic Substances Industry Net Profit MarginSep 30 2023 MRQ Net IncomeSep 30 2023 MRQ Revenue




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com